CoChat

RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry

Open access
Jung, Heiyoun, Hsiung, Benjamin, Pestal, Kathleen, Procyk, Emily, Raulet, David H. · 2012 · Journal of Experimental Medicine

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

The NKG2D stimulatory receptor expressed by natural killer cells and T cell subsets recognizes cell surface ligands that are induced on transformed and infected cells and facilitate immune rejection of tumor cells. We demonstrate that expression of retinoic acid early inducible gene 1 (RAE-1) family NKG2D ligands in cancer cell lines and proliferating normal cells is coupled directly to cell cycle regulation. Raet1 genes are directly transcriptionally activated by E2F family transcription factors, which play a central role in regulating cell cycle entry. Induction of RAE-1 occurred in primary cell cultures, embryonic brain cells in vivo, and cells in healing skin wounds and, accordingly, wound healing was delayed in mice lacking NKG2D. Transcriptional activation by E2Fs is likely coordinated with posttranscriptional regulation by other stress responses. These findings suggest that cellular proliferation, as occurs in cancer cells but also other pathological conditions, is a key signal tied to immune reactions mediated by NKG2D-bearing lymphocytes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20120565

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. RAE-1e is induced on primary cultured fibroblasts dependent on proliferation. (A) qRT-PCR for Raet1e in RNA from adult C57BL/6 tail tissue (day 0), or 2- or 10-d cultured fibroblasts from the tails, relative to 18s rRNA qRT-PCR results. Raet1e transcript levels were normalized to the day 2 amounts, as they were undetectable in day 0 cells. Means ± SD are shown. **, P < 0.005, unpaired Student’s t test. (B) Tail fibroblasts harvested after 1–6 d of in vitro culture were stained with RAE-1ε antibody. Shaded histogram represents isotype control staining. (C) qRT-PCR for Raet1e, Raet1d, Mult1, and H60b in RNA from adult C57BL/6 tail tissue (d0), or 5-d cultured fibroblasts (d5) from the tails, relative to 18s rRNA qRT-PCR results. Means ± SD are shown. (D) Tail fibroblasts were cultured with DMSO or with 10 mM LY294002 or 25 mM Roscovitine for the indicated number of days and stained for RAE-1ε. (E) After 8 d of primary culture in 10% FCS, fibroblasts were treated with LY294002, Roscovitine, or vehicle (DMSO) for 3 d and stained for RAE-1ε (top). RAE-1ε staining was tested after washing the treated cells from the top panel and reculturing for an additional 3 d (bottom). (F) TRAMP-C2 and MC38 tumor cell lines were treated with Roscovitine or vehicle (DMSO) for 1 or 3 d and stained for RAE-1ε. Shaded histograms represent isotype control staining of DMSO-treated samples. (G) HCT116 cells were serum starved or treated with Roscovitine or vehicle (DMSO) for 3 d and stained for MICA/B or UBLP2. Dead (7-AAD+) cells were excluded in all of the experiments above, except one in A. Data in A, B, and D were repeated >10× with similar results, and data in C, E, F, and G are representative of two to three independent experiments.
Figure 1. RAE-1e is induced on primary cultured fibroblasts dependent on proliferation. (A) qRT-PCR for Raet1e in RNA from adult C57BL/6 tail tissue (day 0), or 2- or 10-d cultured fibroblasts from the tails, relative to 18s rRNA qRT-PCR results. Raet1e transcript levels were normalized to the day 2 amounts, as they were undetectable in day 0 cells. Means ± SD are shown. **, P < 0.005, unpaired Student’s t test. (B) Tail fibroblasts harvested after 1–6 d of in vitro culture were stained with RAE-1ε antibody. Shaded histogram represents isotype control staining. (C) qRT-PCR for Raet1e, Raet1d, Mult1, and H60b in RNA from adult C57BL/6 tail tissue (d0), or 5-d cultured fibroblasts (d5) from the tails, relative to 18s rRNA qRT-PCR results. Means ± SD are shown. (D) Tail fibroblasts were cultured with DMSO or with 10 mM LY294002 or 25 mM Roscovitine for the indicated number of days and stained for RAE-1ε. (E) After 8 d of primary culture in 10% FCS, fibroblasts were treated with LY294002, Roscovitine, or vehicle (DMSO) for 3 d and stained for RAE-1ε (top). RAE-1ε staining was tested after washing the treated cells from the top panel and reculturing for an additional 3 d (bottom). (F) TRAMP-C2 and MC38 tumor cell lines were treated with Roscovitine or vehicle (DMSO) for 1 or 3 d and stained for RAE-1ε. Shaded histograms represent isotype control staining of DMSO-treated samples. (G) HCT116 cells were serum starved or treated with Roscovitine or vehicle (DMSO) for 3 d and stained for MICA/B or UBLP2. Dead (7-AAD+) cells were excluded in all of the experiments above, except one in A. Data in A, B, and D were repeated >10× with similar results, and data in C, E, F, and G are representative of two to three independent experiments.CC BY-NC-SA · PubMed Central
Figure 2. Proliferation is required for RAE-1ε expression on primary fibroblasts. (A) Freshly prepared B6 adult mouse tail fibroblasts were cultured in media supplemented with 2 or 10% serum for ∼3–7 d and harvested for flow cytometry analysis. (B and C) Fibroblasts that had been cultured for >1 mo were serum starved for 1–3 d and processed for staining (B) or RNA analysis (C). Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. (D) Samples of serum-starved cells were supplemented with 10% serum and cultured for an additional 3 d. Data in A–D are representative of at least four experiments. (E) Proliferating (Untreated) fibroblasts, or fibroblasts subjected to serum starvation or treatment with LY294002, Roscovitine, or DMSO for 3 d, were stained with 7-AAD and Annexin-V to detect dead and apoptotic cells. (F) Fibroblasts that were serum starved for 3 d were fed with serum for 2 or 3 d in the presence of BrdU to label proliferating cells, before staining the cells intracellularly with BrdU antibodies. (G) Proliferating fibroblasts were serum starved for 3 d before adding 10% serum and BrdU (bottom) or BrdU only (top). After 24 h, cells were stained with BrdU and RAE-1ε antibodies. Gated BrdU+ and BrdU− cells were examined for RAE-1ε expression after excluding 7-AAD+ (dead) cells. (H) Proliferating fibroblasts were stained with RAE-1 antibody, permeabilized, and stained with propidium iodide. Cells in G1, S, or G2 phases of the cell cycle (left) were examined for RAE-1ε expression (right). (I) Freshly prepared tail cells were cultured on fibronectin-coated plates in DMEM supplemented with 10% serum, 100 ng/ml EGF, or no growth factor (−EGF) for 3 d. Cell counts (right, cells/culture) and RAE-1ε staining (left) are shown. Data in E–I are representative of two experiments. (J) Proliferating fibroblasts (Prol) or fibroblasts that were serum starved for 3 d (Starved) were used as target cells for IL-2–activated natural killer cells (LAKs) prepared from NKG2D-deficient (KO) mice or NKG2D WT littermate controls. NKG2D antibody was added to a reaction of WT LAKs with proliferating target cells to block the NKG2D receptor (WT/Prol/MI6). Means ± SD are shown. Data in J are representative of four experiments.
Figure 2. Proliferation is required for RAE-1ε expression on primary fibroblasts. (A) Freshly prepared B6 adult mouse tail fibroblasts were cultured in media supplemented with 2 or 10% serum for ∼3–7 d and harvested for flow cytometry analysis. (B and C) Fibroblasts that had been cultured for >1 mo were serum starved for 1–3 d and processed for staining (B) or RNA analysis (C). Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. (D) Samples of serum-starved cells were supplemented with 10% serum and cultured for an additional 3 d. Data in A–D are representative of at least four experiments. (E) Proliferating (Untreated) fibroblasts, or fibroblasts subjected to serum starvation or treatment with LY294002, Roscovitine, or DMSO for 3 d, were stained with 7-AAD and Annexin-V to detect dead and apoptotic cells. (F) Fibroblasts that were serum starved for 3 d were fed with serum for 2 or 3 d in the presence of BrdU to label proliferating cells, before staining the cells intracellularly with BrdU antibodies. (G) Proliferating fibroblasts were serum starved for 3 d before adding 10% serum and BrdU (bottom) or BrdU only (top). After 24 h, cells were stained with BrdU and RAE-1ε antibodies. Gated BrdU+ and BrdU− cells were examined for RAE-1ε expression after excluding 7-AAD+ (dead) cells. (H) Proliferating fibroblasts were stained with RAE-1 antibody, permeabilized, and stained with propidium iodide. Cells in G1, S, or G2 phases of the cell cycle (left) were examined for RAE-1ε expression (right). (I) Freshly prepared tail cells were cultured on fibronectin-coated plates in DMEM supplemented with 10% serum, 100 ng/ml EGF, or no growth factor (−EGF) for 3 d. Cell counts (right, cells/culture) and RAE-1ε staining (left) are shown. Data in E–I are representative of two experiments. (J) Proliferating fibroblasts (Prol) or fibroblasts that were serum starved for 3 d (Starved) were used as target cells for IL-2–activated natural killer cells (LAKs) prepared from NKG2D-deficient (KO) mice or NKG2D WT littermate controls. NKG2D antibody was added to a reaction of WT LAKs with proliferating target cells to block the NKG2D receptor (WT/Prol/MI6). Means ± SD are shown. Data in J are representative of four experiments.CC BY-NC-SA · PubMed Central
Figure 3. RAE-1ε induction in primary fibroblast cultures is independent of various stress pathways. (A) Fibroblasts were treated with DMSO, Roscovitine, or with a mixture of SB218078 (CHK1 inhibitor) and KU55933 (ATM inhibitor) for 3 d (left). Fibroblasts freshly prepared from Atrfloxed/− Cre-ERT2+ mouse tails were cultured in the absence (Atr+/−) or presence (Atr−/−) of Tamoxifen (to induce Cre and delete loxP-flanked Atr alleles) for 5 d, and KU55933 or DMSO was added for the last 3 d (right). (B) Fibroblasts were freshly prepared from knockout mice that lacked the indicated genes (dashed lines) or WT controls (solid lines) and cultured for 5 d. Dead (7-AAD+) cells were excluded. Each panel is representative of at least three independent experiments.
Figure 3. RAE-1ε induction in primary fibroblast cultures is independent of various stress pathways. (A) Fibroblasts were treated with DMSO, Roscovitine, or with a mixture of SB218078 (CHK1 inhibitor) and KU55933 (ATM inhibitor) for 3 d (left). Fibroblasts freshly prepared from Atrfloxed/− Cre-ERT2+ mouse tails were cultured in the absence (Atr+/−) or presence (Atr−/−) of Tamoxifen (to induce Cre and delete loxP-flanked Atr alleles) for 5 d, and KU55933 or DMSO was added for the last 3 d (right). (B) Fibroblasts were freshly prepared from knockout mice that lacked the indicated genes (dashed lines) or WT controls (solid lines) and cultured for 5 d. Dead (7-AAD+) cells were excluded. Each panel is representative of at least three independent experiments.CC BY-NC-SA · PubMed Central
Figure 4. Induction of RAE-1ε on cells in highly proliferative tissues in vivo. (A) Single cell suspensions from E14 and E18 fetal brains were stained with RAE-1ε. Dead (7AAD+) cells were excluded by gating. (B) 9-µm frozen sections of E14 brain were stained with RAE-1ε antibody (green) and DAPI (blue). Bars, 25 µm. (C) Killing of day 14 fetal brain cells by NK cells from Klrk1+/+ or Klrk1−/− mice were measured using LIVE/DEAD fixable dead cell stain kits, gating on CD45-negative cells. Effector/target ratio = 9:1. Means ± SD are shown. (D) BrdU incorporation of embryonic E14 or E18 brain cells after injecting pregnant mothers with BrdU 16 h before sacrifice. Mean fluorescence intensity (MFI) of the entire population is shown on the right. Gated BrdU+ and BrdU− cells stained similarly with RAE-1, consistent with the finding that nearly all the brain cells are proliferating at day 14 (see text). Data in this figure are representative of two to four independent experiments.
Figure 4. Induction of RAE-1ε on cells in highly proliferative tissues in vivo. (A) Single cell suspensions from E14 and E18 fetal brains were stained with RAE-1ε. Dead (7AAD+) cells were excluded by gating. (B) 9-µm frozen sections of E14 brain were stained with RAE-1ε antibody (green) and DAPI (blue). Bars, 25 µm. (C) Killing of day 14 fetal brain cells by NK cells from Klrk1+/+ or Klrk1−/− mice were measured using LIVE/DEAD fixable dead cell stain kits, gating on CD45-negative cells. Effector/target ratio = 9:1. Means ± SD are shown. (D) BrdU incorporation of embryonic E14 or E18 brain cells after injecting pregnant mothers with BrdU 16 h before sacrifice. Mean fluorescence intensity (MFI) of the entire population is shown on the right. Gated BrdU+ and BrdU− cells stained similarly with RAE-1, consistent with the finding that nearly all the brain cells are proliferating at day 14 (see text). Data in this figure are representative of two to four independent experiments.CC BY-NC-SA · PubMed Central
Figure 5. Expression of RAE-1ε in healing skin wounds. (A) BrdU was injected i.p. 2 d after imparting skin wounds, and the mice were sacrificed 1 d later. BrdU+ cells (red) and CD45+ cells (green) in sections of healing skin wounds. Examples of clear BrdU staining are indicated with arrows. D, dermis; E, epidermis. DAPI staining (blue) was not well defined as a result of permeabilization conditions. Two different sections are shown. (B) Skin segments from unwounded mice (d0), or skin surrounding and including wounds that had been imparted 1–3 d earlier were excised. Raet1e mRNA was quantified by qRT-PCR and normalized to 18s rRNA qRT-PCR results (n = 3). Means ± SD are shown. (C) Sections from wounded (3 d earlier) or unwounded skin were stained with RAE-1ε antibody or isotype control antibody (green) with DAPI (blue). In some experiments, the specificity of staining was confirmed by adding soluble recombinant RAE-1ε-Ig before RAE-1ε antibody to block the staining. D, dermis; E, epidermis. RAE-1ε staining of the epidermal layer was consistently observed even in unwounded skin, but staining deeper in the tissue was restricted to wounded skin. Data in A–C are representative at least four experiments. Bars, 25 µm. (D) Three replicate experiments showing delayed wound healing in NKG2D-deficient (Klrk1−/−) mice compared with NKG2D WT (Klrk1+/+) littermates. After application of full thickness wounds, the area of the wound opening was determined on subsequent days. n = 5–11 wounds depending on the experiment. Means ± SD are shown. The asterisks denote significance (*, P < 0.05; **, P < 0.005; ***, P < 0.0005). (E) Analysis of wound closure in WT, TCR-δ–deficient (Tcrd−/−), or NKG2D-deficient mice. After application of full thickness wounds, the area of the wound opening was determined on the subsequent days. Means ± SD are shown. P < 0.05 for WT versus Tcrd−/− at days 1 and 2; P < 0.05 for WT versus Klrk1−/− at days 1 and 5. n = 11–25 wounds depending on the combinations. The comparison of WT versus Klrk1−/− was performed four times but the comparison including Tcrd−/− was done only once.
Figure 5. Expression of RAE-1ε in healing skin wounds. (A) BrdU was injected i.p. 2 d after imparting skin wounds, and the mice were sacrificed 1 d later. BrdU+ cells (red) and CD45+ cells (green) in sections of healing skin wounds. Examples of clear BrdU staining are indicated with arrows. D, dermis; E, epidermis. DAPI staining (blue) was not well defined as a result of permeabilization conditions. Two different sections are shown. (B) Skin segments from unwounded mice (d0), or skin surrounding and including wounds that had been imparted 1–3 d earlier were excised. Raet1e mRNA was quantified by qRT-PCR and normalized to 18s rRNA qRT-PCR results (n = 3). Means ± SD are shown. (C) Sections from wounded (3 d earlier) or unwounded skin were stained with RAE-1ε antibody or isotype control antibody (green) with DAPI (blue). In some experiments, the specificity of staining was confirmed by adding soluble recombinant RAE-1ε-Ig before RAE-1ε antibody to block the staining. D, dermis; E, epidermis. RAE-1ε staining of the epidermal layer was consistently observed even in unwounded skin, but staining deeper in the tissue was restricted to wounded skin. Data in A–C are representative at least four experiments. Bars, 25 µm. (D) Three replicate experiments showing delayed wound healing in NKG2D-deficient (Klrk1−/−) mice compared with NKG2D WT (Klrk1+/+) littermates. After application of full thickness wounds, the area of the wound opening was determined on subsequent days. n = 5–11 wounds depending on the experiment. Means ± SD are shown. The asterisks denote significance (*, P < 0.05; **, P < 0.005; ***, P < 0.0005). (E) Analysis of wound closure in WT, TCR-δ–deficient (Tcrd−/−), or NKG2D-deficient mice. After application of full thickness wounds, the area of the wound opening was determined on the subsequent days. Means ± SD are shown. P < 0.05 for WT versus Tcrd−/− at days 1 and 2; P < 0.05 for WT versus Klrk1−/− at days 1 and 5. n = 11–25 wounds depending on the combinations. The comparison of WT versus Klrk1−/− was performed four times but the comparison including Tcrd−/− was done only once.CC BY-NC-SA · PubMed Central
Figure 6. Transcriptional regulation of Raet1e by proliferation. (A) Nuclear run-on assays were performed in the presence of Br-UTP in proliferating fibroblasts (Serum) or 3 d serum-starved fibroblasts. Labeled nuclear RNA was immunoprecipitated with Br-U antibody, reverse transcribed, and subjected to qPCR. As a control, the analysis was performed with proliferating fibroblasts that were provided UTP instead of Br-UTP (UTP ctrl). No RT: reverse transcriptase was excluded from the RT reaction using RNA from proliferating fibroblasts. Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. (B) Unbiased cap-dependent 5′ RACE PCR was performed to define the 5′ terminal end of the Raet1e transcripts. RNA samples from a panel of Raet1e+ cells were subject to 5′ RACE. In the first PCR reaction, a primer for the 5′ adapter was combined with p4 as the 3′ primer. The product was subjected to nested PCR with the same 5′ primer and primers p1, p2, or p3 as 3′ primers. Numerous splice variants were deduced from the sequences of the various products. Exon 3 is variably included in different mRNAs. Exon 2 was included, albeit rarely, in transcripts from one cell line, Nobo1 (not depicted). Exon 5, described in a previous study (Girardi et al., 2001), was not included in any of the Raet1e sequences we detected. (C) Activity of the Raet1e promoter in cell lines. The pGL3 vector containing the Raet1e promoter fragment in forward (F) or reverse (R) orientations was transfected into RAE-1–expressing Tramp-C1 and Nobo1 cells or RAE-1–negative WEHI 7.1 cells and the cells were incubated in 10% serum for 24 h. The activity of the SV40 promoter in the same reporter plasmid is shown for comparison (S). Means ± SD are shown. (D) Fibroblasts were transfected with pGL3 basic vectors containing the Raet1e promoter (−204 to +70) in forward or reverse orientation. The cells were incubated without serum (−) or with 10% serum (+) for 24 h (n = 3). Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. Each panel in this figure is representative of at least three experiments.
Figure 6. Transcriptional regulation of Raet1e by proliferation. (A) Nuclear run-on assays were performed in the presence of Br-UTP in proliferating fibroblasts (Serum) or 3 d serum-starved fibroblasts. Labeled nuclear RNA was immunoprecipitated with Br-U antibody, reverse transcribed, and subjected to qPCR. As a control, the analysis was performed with proliferating fibroblasts that were provided UTP instead of Br-UTP (UTP ctrl). No RT: reverse transcriptase was excluded from the RT reaction using RNA from proliferating fibroblasts. Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. (B) Unbiased cap-dependent 5′ RACE PCR was performed to define the 5′ terminal end of the Raet1e transcripts. RNA samples from a panel of Raet1e+ cells were subject to 5′ RACE. In the first PCR reaction, a primer for the 5′ adapter was combined with p4 as the 3′ primer. The product was subjected to nested PCR with the same 5′ primer and primers p1, p2, or p3 as 3′ primers. Numerous splice variants were deduced from the sequences of the various products. Exon 3 is variably included in different mRNAs. Exon 2 was included, albeit rarely, in transcripts from one cell line, Nobo1 (not depicted). Exon 5, described in a previous study (Girardi et al., 2001), was not included in any of the Raet1e sequences we detected. (C) Activity of the Raet1e promoter in cell lines. The pGL3 vector containing the Raet1e promoter fragment in forward (F) or reverse (R) orientations was transfected into RAE-1–expressing Tramp-C1 and Nobo1 cells or RAE-1–negative WEHI 7.1 cells and the cells were incubated in 10% serum for 24 h. The activity of the SV40 promoter in the same reporter plasmid is shown for comparison (S). Means ± SD are shown. (D) Fibroblasts were transfected with pGL3 basic vectors containing the Raet1e promoter (−204 to +70) in forward or reverse orientation. The cells were incubated without serum (−) or with 10% serum (+) for 24 h (n = 3). Means ± SD are shown. ***, P < 0.0005, unpaired Student’s t test. Each panel in this figure is representative of at least three experiments.CC BY-NC-SA · PubMed Central
Figure 7. E2F transcription factors bind to the Raet1e promoter. (A) Putative E2F binding sites with consensus sequence TTTSSCGC (S = C or G, with up to two mismatches allowed only in the three T residues (Schulze et al., 1995; Bieda et al., 2006; Rabinovich et al., 2008) were localized throughout the Raet1e gene. (B) A schematic of the 5′end of the Raet1e locus. The region from −60 to +1 is enlarged to show the putative E2F binding sites. The CpG island is shown as a hatched box. (C) Competition EMSA showing binding of a Raet1e promoter fragment to E2F in fibroblast nuclear extracts. A labeled probe containing E2F sites from the DHFR promoter was incubated with fibroblast nuclear extract (NE) before gel analysis. Binding was competed away by preincubating the extract with a 100-, 200-, or 400-fold excess of unlabeled oligonucleotides, including the same DHFR promoter oligonucleotide, a Raet1e promoter oligonucleotide, or mutated versions of these oligonucleotides in which the E2F binding sites were replaced with nonfunctional sites (Mut DHFR and Mut Raet1e). (D) ChIP assays showing association of E2F1, E2F2, and E2F3 with the Raet1e promoter in proliferating (Serum) or starved fibroblasts. Control IP with IgG isotype is shown. PCR was performed with PCR primers designed to yield a 165 bp product corresponding to −147 to +18 of the Raet1e promoter (left) or primers of the p107 promoter region were used (right). The input lane represented 0.3% of the amount of chromatin used in the ChIP assays. The gel was cut at every set of four semiquantitative PCR and aligned. Black lines indicate that intervening lanes were spliced out. Each panel in this figure is representative of four independent experiments.
Figure 7. E2F transcription factors bind to the Raet1e promoter. (A) Putative E2F binding sites with consensus sequence TTTSSCGC (S = C or G, with up to two mismatches allowed only in the three T residues (Schulze et al., 1995; Bieda et al., 2006; Rabinovich et al., 2008) were localized throughout the Raet1e gene. (B) A schematic of the 5′end of the Raet1e locus. The region from −60 to +1 is enlarged to show the putative E2F binding sites. The CpG island is shown as a hatched box. (C) Competition EMSA showing binding of a Raet1e promoter fragment to E2F in fibroblast nuclear extracts. A labeled probe containing E2F sites from the DHFR promoter was incubated with fibroblast nuclear extract (NE) before gel analysis. Binding was competed away by preincubating the extract with a 100-, 200-, or 400-fold excess of unlabeled oligonucleotides, including the same DHFR promoter oligonucleotide, a Raet1e promoter oligonucleotide, or mutated versions of these oligonucleotides in which the E2F binding sites were replaced with nonfunctional sites (Mut DHFR and Mut Raet1e). (D) ChIP assays showing association of E2F1, E2F2, and E2F3 with the Raet1e promoter in proliferating (Serum) or starved fibroblasts. Control IP with IgG isotype is shown. PCR was performed with PCR primers designed to yield a 165 bp product corresponding to −147 to +18 of the Raet1e promoter (left) or primers of the p107 promoter region were used (right). The input lane represented 0.3% of the amount of chromatin used in the ChIP assays. The gel was cut at every set of four semiquantitative PCR and aligned. Black lines indicate that intervening lanes were spliced out. Each panel in this figure is representative of four independent experiments.CC BY-NC-SA · PubMed Central
Figure 8. Transactivation of Raet1e expression by E2Fs, and siRNA knockdowns. (A and B) Fibroblasts were transfected with 50 ng pGL3 vector containing the Raet1e promoter segment or corresponding segments in which putative E2F sites (A) or a putative MYC site (B) were mutated, along with varying amounts of pcDNA encoding E2F1 or MYC (0, 100, 250, or 750 ng in the left panel of A, and 0, 250, or 750 ng in the remaining panels). Cells were incubated in 0% serum for 24 h except the 10% serum sample in the left panel of A. Open and shaded boxes represent E2F and MYC sites, respectively; Xs indicate mutations that prevent factor binding. (C) Primary fibroblasts were transfected with the reporter plasmid containing the WT Raet1e promoter or the promoter in which both E2F sites were mutated, and the MYC site was mutated or all three sites were mutated. The transfected cells were incubated for 40 h in 0 or 10% serum before analysis of reporter activity. (D) Endogenous Raet1e expression in fibroblasts transduced with E2F1, E2F2, E2F3, or GFP only (empty) and cultured for 48 h in the absence of serum. DHFR is a known E2F target gene. n = 3. (E) siRNA knockdowns of E2Fs separately or together inhibit Raet1e expression in proliferating fibroblasts 48 h later (P < 0.0005 for all E2F groups vs. negative control). Data were normalized to 18S rRNA amounts and then to the all star negative control sample. n = 8−9. Each result in this figure is representative of at least four independent experiments. The asterisks denote significance (*, P < 0.05; **, P < 0.005).
Figure 8. Transactivation of Raet1e expression by E2Fs, and siRNA knockdowns. (A and B) Fibroblasts were transfected with 50 ng pGL3 vector containing the Raet1e promoter segment or corresponding segments in which putative E2F sites (A) or a putative MYC site (B) were mutated, along with varying amounts of pcDNA encoding E2F1 or MYC (0, 100, 250, or 750 ng in the left panel of A, and 0, 250, or 750 ng in the remaining panels). Cells were incubated in 0% serum for 24 h except the 10% serum sample in the left panel of A. Open and shaded boxes represent E2F and MYC sites, respectively; Xs indicate mutations that prevent factor binding. (C) Primary fibroblasts were transfected with the reporter plasmid containing the WT Raet1e promoter or the promoter in which both E2F sites were mutated, and the MYC site was mutated or all three sites were mutated. The transfected cells were incubated for 40 h in 0 or 10% serum before analysis of reporter activity. (D) Endogenous Raet1e expression in fibroblasts transduced with E2F1, E2F2, E2F3, or GFP only (empty) and cultured for 48 h in the absence of serum. DHFR is a known E2F target gene. n = 3. (E) siRNA knockdowns of E2Fs separately or together inhibit Raet1e expression in proliferating fibroblasts 48 h later (P < 0.0005 for all E2F groups vs. negative control). Data were normalized to 18S rRNA amounts and then to the all star negative control sample. n = 8−9. Each result in this figure is representative of at least four independent experiments. The asterisks denote significance (*, P < 0.05; **, P < 0.005).CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 144

Metadata

Authors
Jung, H., Hsiung, B., Pestal, K., Procyk, E., & Raulet, D. H.
Affiliations
University of California, Berkeley (US)
Corresponding author
Raulet, David H.
Venue
Journal of Experimental Medicine
Published
2012-11-19
Volume
209
Issue
13
Pages
2409-2422
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2140159527
Cited by
123
References
48
Citations by year
2026: 6 · 2025: 6 · 2024: 2 · 2023: 8 · 2022: 7 · 2021: 1 · 2020: 13 · 2019: 5 · 2018: 14 · 2017: 11 · 2016: 12 · 2015: 14 · 2014: 13 · 2013: 11
FWCI
5.29
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
Funders
National Institute of Allergy and Infectious Diseases (R01AI039642)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
NKG2D, E2F transcription factors, cell cycle entry, natural killer cells, T cells, transcriptional activation, wound healing, cancer cell lines, stress response, post-transcriptional regulation
MeSH terms
Animals, Cells, Cultured, Ligands, Lymphocytes, Membrane Proteins, Mice, Inbred C57BL, Stress, Physiological, Transcription, Genetic, Wound Healing, Signal Transduction, Gene Expression, Mice, Knockout, Cell Line, Tumor, Cell Proliferation, E2F Transcription Factors, Mice, NK Cell Lectin-Like Receptor Subfamily K, Cell Cycle Checkpoints

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. https://app.cochat.ai/papers/10.1084/jem.20120565
The paper
Jung, H., Hsiung, B., Pestal, K., Procyk, E., & Raulet, D. H. (2012). RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20120565

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.